Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$1.48 - $6.22 $16,414 - $68,986
-11,091 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$8.77 - $18.29 $97,268 - $202,854
11,091 New
11,091 $99,000
Q1 2021

May 13, 2021

SELL
$16.57 - $28.65 $167,191 - $289,078
-10,090 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$15.44 - $24.23 $155,789 - $244,480
10,090 New
10,090 $222,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $25.5M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.